| scholarly article | Q13442814 |
| P50 | author | Marina E Emborg | Q89900494 |
| P2093 | author name string | Colleen F Moore | |
| Andres Mejia | |||
| Heather A Simmons | |||
| Viktoriya Bondarenko | |||
| Jeanette M Metzger | |||
| Helen N Matsoff | |||
| Rachel A Fleddermann | |||
| Alexandra D Zinnen | |||
| P2860 | cites work | Tyrosine hydroxylase and regulation of dopamine synthesis | Q21710723 |
| Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma | Q24311702 | ||
| PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL | Q24311741 | ||
| An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 | Q24599479 | ||
| Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 | Q24679555 | ||
| The methodology of TSPO imaging with positron emission tomography | Q26778370 | ||
| Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies | Q26795984 | ||
| Oxidative stress and Parkinson's disease | Q26798897 | ||
| Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification | Q27887261 | ||
| Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study | Q28546721 | ||
| Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. | Q30357397 | ||
| Molecular imaging: current status and emerging strategies | Q30474579 | ||
| Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys | Q31059759 | ||
| CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior | Q33609100 | ||
| Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis | Q33908068 | ||
| 2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET. | Q39475357 | ||
| Peroxisome proliferator-activated receptor-{gamma} suppresses CYP11B2 expression and aldosterone production | Q39627792 | ||
| The Adrenal Medulla and Parkinson's Disease | Q40494278 | ||
| Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation | Q40513320 | ||
| Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophy. | Q42289247 | ||
| Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects | Q42439893 | ||
| Differential modulatory effects of rosiglitazone and pioglitazone on white adipose tissue in db/db mice | Q42932291 | ||
| Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson's disease | Q42970937 | ||
| Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease | Q43185310 | ||
| Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells | Q43760306 | ||
| Orthostatic hypotension from sympathetic denervation in Parkinson's disease | Q43968847 | ||
| Progressive loss of cardiac sympathetic innervation in Parkinson's disease | Q44124971 | ||
| Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone | Q44183076 | ||
| Histological study on the distribution of autonomic nerves in the human heart | Q44367419 | ||
| Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease | Q44531220 | ||
| Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver. | Q46013813 | ||
| Pioglitazone promotes peripheral nerve remyelination after crush injury through CD36 upregulation | Q46323803 | ||
| Profound cardiac sympathetic denervation occurs in Parkinson disease | Q46392026 | ||
| Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo | Q46458744 | ||
| Insulin-induced translocation of CD36 to the plasma membrane is reversible and shows similarity to that of GLUT4. | Q46826676 | ||
| Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease | Q46851020 | ||
| Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease | Q46915950 | ||
| Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner | Q47921885 | ||
| PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice. | Q48273067 | ||
| Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential | Q48670684 | ||
| Cardiac sympathetic denervation predicts PD in at-risk individuals. | Q50070708 | ||
| Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging. | Q51532478 | ||
| Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells. | Q51728404 | ||
| Mechanistic insights into the augmented effect of bone marrow mesenchymal stem cells and thiazolidinediones in streptozotocin-nicotinamide induced diabetic rats. | Q55516069 | ||
| Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression | Q58549943 | ||
| Myocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetic metabolism to prevent progression of pressure overload-induced heart failure | Q58786673 | ||
| Thiazolidinediones and Rexinoids Induce Peroxisome Proliferator-Activated Receptor-Coactivator (PGC)-1α Gene Transcription: An Autoregulatory Loop Controls PGC-1α Expression in Adipocytes via Peroxisome Proliferator-Activated Receptor-γ Coactivati | Q60636879 | ||
| Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease | Q61640905 | ||
| Decreased catecholamine content in parkinsonian adrenal medullae | Q69963042 | ||
| Adrenal medulla and Parkinson's disease | Q72386207 | ||
| Evaluation of sympathetic nerve terminals with [(11)C]epinephrine and [(11)C]hydroxyephedrine and positron emission tomography | Q73419535 | ||
| Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice | Q79401820 | ||
| The effect of beta-adrenergic and peroxisome proliferator-activated receptor-gamma stimulation on target genes related to lipid metabolism in human subcutaneous adipose tissue | Q79918285 | ||
| Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons | Q80488890 | ||
| Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson's disease? | Q84033190 | ||
| Role of cardiac sympathetic nerves in preventing orthostatic hypotension in Parkinson's disease | Q87162518 | ||
| In vivo imaging of inflammation and oxidative stress in a nonhuman primate model of cardiac sympathetic neurodegeneration | Q90432232 | ||
| Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease | Q33951094 | ||
| Clinical progression in Parkinson disease and the neurobiology of axons. | Q34052764 | ||
| Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates | Q34061568 | ||
| Increased FAT/CD36 cycling and lipid accumulation in myotubes derived from obese type 2 diabetic patients | Q34110605 | ||
| Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-γ-knockout (CM-PGKO) mice | Q34259900 | ||
| Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. | Q34277079 | ||
| MDS clinical diagnostic criteria for Parkinson's disease | Q34498274 | ||
| Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain | Q34893444 | ||
| The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys | Q35196195 | ||
| (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease | Q35452165 | ||
| Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease | Q35486162 | ||
| Dysautonomia in Parkinson's disease: neurocardiological abnormalities | Q35565719 | ||
| Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet | Q35762949 | ||
| Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET | Q36247833 | ||
| PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle | Q36825520 | ||
| Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists | Q36992256 | ||
| Disease duration and the integrity of the nigrostriatal system in Parkinson's disease | Q37043102 | ||
| High circulating levels of RBP4 and mRNA levels of aP2, PGC-1alpha and UCP-2 predict improvement in insulin sensitivity following pioglitazone treatment of drug-naïve type 2 diabetic subjects | Q37178681 | ||
| Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects | Q37334469 | ||
| Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. | Q37370209 | ||
| 8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis | Q37468730 | ||
| Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis | Q37544921 | ||
| Effects and Potential Mechanisms of Pioglitazone on Lipid Metabolism in Obese Diabetic KKAy Mice | Q37706430 | ||
| Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease | Q37711062 | ||
| Role of the PPAR-γ system in normal and tumoral pituitary corticotropic cells and adrenal cells. | Q37786919 | ||
| Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis | Q37834857 | ||
| Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis | Q37957562 | ||
| Neuroinflammation in Parkinson's disease. | Q37968058 | ||
| Age-Associated Pathology in Rhesus Macaques (Macaca mulatta). | Q38728843 | ||
| Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM. | Q38760751 | ||
| Repeated Measures Correlation | Q38821902 | ||
| The effect of pioglitazone on aldosterone and cortisol production in HAC15 human adrenocortical carcinoma cells | Q38974109 | ||
| From fat to FAT (CD36/SR-B2): Understanding the regulation of cellular fatty acid uptake | Q39053028 | ||
| Iodine-123 metaiodobenzylguanidine scintigraphy for the assessment of cardiac sympathetic innervation and the relationship with cardiac autonomic function in healthy adults using standardized methods | Q39145397 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | e0226999 | |
| P577 | publication date | 2020-01-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Post mortem evaluation of inflammation, oxidative stress, and PPARγ activation in a nonhuman primate model of cardiac sympathetic neurodegeneration | |
| P478 | volume | 15 |
Search more.